Overview of new immunosuppressive therapies

Thomas E. Nevins

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


This review covers the new immunosuppressive drugs that have appeared in the past 5 years. It begins with the newest formulation (Neoral, Sandoz Pharmaceuticals, East Hanover, NJ, USA) of the clinically 'mature' drug cyclosporin A and then reviews the literature on tacrolimus, sirolimus, and mycophenolate mofetil. In each case, the emphasis is on the evolution of experience with the drug and on the questions that the drug poses for pediatricians considering the risk-benefit ratio of the drug in children. (C) 2000 Lippincott Williams and Wilkins, Inc.

Original languageEnglish (US)
Pages (from-to)146-150
Number of pages5
JournalCurrent Opinion in Pediatrics
Issue number2
StatePublished - 2000


Dive into the research topics of 'Overview of new immunosuppressive therapies'. Together they form a unique fingerprint.

Cite this